Status:
TERMINATED
Kidney Information Network for Disease Research and Education
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Genzyme, a Sanofi Company
Scott and White Hospital & Clinic
Conditions:
ESRD
Fabry Disease
Eligibility:
All Genders
18-65 years
Brief Summary
In this study, Investigators will conduct a prospective cohort study of dialysis patients by collecting research-quality information on patient characteristics, comorbid diseases and laboratory marker...
Detailed Description
KINDRED is a prospective observational cohort study that will enroll up to 5,000 dialysis patients throughout the United States with and without known diagnosis of Fabry disease but at risk for Fabry ...
Eligibility Criteria
Inclusion
- Adults between 18 and 65 with ESRD undergoing dialysis.
Exclusion
- Kidney biopsy unlikely to be Fabry disease; those with a diagnosis that is clinically or biochemically proven not to be Fabry disease.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 21 2019
Estimated Enrollment :
338 Patients enrolled
Trial Details
Trial ID
NCT03321604
Start Date
January 1 2018
End Date
November 21 2019
Last Update
February 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02214